Caplin Point Laboratories Limited (CAPLIPOINT) — Announcement | 11 July 2026

StockFin.ai

Try Free

📢 Key Event
Company received SEBI-mandated confirmation certificate for shareholding records

💡 Investor Takeaway
This confirms accurate shareholding records and compliance with regulatory standards for investors.

Caplin Point Laboratories announced receipt of a SEBI-mandated confirmation certificate from its registrar confirming dematerialized securities for the quarter ended June 30, 2026, ensuring compliance with shareholding records and exchange listings. This regulatory update validates the company's adherence to depositary participant protocols and maintains transparent ownership tracking for investors.

📄 View Original Announcement (PDF)

📊 Stock Analysis — CAPLIPOINT ✨ Ask AI About This

About Caplin Point Laboratories Limited (CAPLIPOINT)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹15,193.22 Cr P/E: 29.5

View full CAPLIPOINT stock details →

📡 Get AI alerts when CAPLIPOINT files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CAPLIPOINT — Free

💡 Ask AI about this filing

"How does this affect CAPLIPOINT margins?" "Compare with last quarter results" "What should investors watch for?"

Ask AI Free →

📊 More CAPLIPOINT filings

See all CAPLIPOINT filings →

🔥 Also filed on 11 July 2026

AFIL Akme Fintrade (India) Limited Annual Report DLF DLF Limited Annual Report AVANTEL Avantel Limited Corporate Action DLF DLF Limited Corporate Action BAJAJCON Bajaj Consumer Care Limited Annual Report BILVYAPAR BIL VYAPAR LIMITED Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when CAPLIPOINT files new disclosures

Track CAPLIPOINT filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track CAPLIPOINT — Free

Free account · 2 AI queries/day